Evaluation of the Quality of the Treatment of Chronic Eczema

Abstrak

this article attempts to reveal the main reasons to compare and evaluate the effectiveness of re-D3-PUVA (a combination of PUVA, oral isotretinoin, a synthetic analogue of vitamin D3 - external calcipotriol), PUVA techniques, conservative therapy in the treatment of chronic eczema of the palms and soles. To carry out scientific work, the author conducted a study of 73 patients aged 16–67 years (40 women and 33 men). The duration of the disease ranged from 2 to 25 years, the form of the disease was severe, the course was torpid, and there was no remission for the last 6 months. The severity of the disease and treatment outcomes were assessed by the clinical picture and dermatological indexes: determining the prevalence and severity of eczema (EASI), dermatological symptom scale index (DSSI), dermatological quality of life index (QLI). The problem in question is still little studied, therefore, requires more thorough research.

Kata Kunci